InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022Business Wire • 03/15/23
InfuSystem to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023Business Wire • 03/13/23
InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022Business Wire • 11/10/22
InfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022Business Wire • 11/02/22
InfuSystem to Participate in Lake Street's 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022Business Wire • 09/07/22
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q2 2022 Results Earnings Call TranscriptSeeking Alpha • 08/06/22
InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain ManagementBusiness Wire • 06/14/22
InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022Business Wire • 05/26/22
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic CompanyBusiness Wire • 04/28/22
InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block CathetersBusiness Wire • 02/22/22
InfuSystem Inks Distribution Pact For Solo-Dex's Continuous Peripheral Nerve Block CathetersBenzinga • 02/22/22
InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021Business Wire • 02/10/22
InfuSystem to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022Business Wire • 02/09/22